Usa testing vaccine Government Usa

COVID-19 monoclonal antibodies, rapid tests in high demand

Reading now: 944
www.cidrap.umn.edu

In the past month, the US government has invested billions of dollars into the pandemic.Think $2.7 billion toward vaccine manufacturing, which is part of the $65 billion decade-long proposal the Biden administration created to prepare for future pandemics.

Or consider the $2 billion it paid for more COVID-19 rapid tests, or the roughly $3 billion worth of monoclonal antibodies it bought in mid-September on top of prior purchases.As the pandemic has shown, though, increased financial support doesn't mean manufacturing lines can suddenly produce a greater volume.

That's why the general public and healthcare workers are dealing with high demand for both monoclonal antibody treatments and COVID-19 rapid tests, and the federal government is

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA